Found: 15
Select item for more details and to access through your institution.
Costs of Newly Funded Proton Therapy Using Time-Driven Activity-Based Costing in The Netherlands.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 516, doi. 10.3390/cancers15020516
- By:
- Publication type:
- Article
Medical Resource Use and Medical Costs for Radiotherapy-Related Adverse Effects: A Systematic Review.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2444, doi. 10.3390/cancers14102444
- By:
- Publication type:
- Article
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5606, doi. 10.3390/cancers13225606
- By:
- Publication type:
- Article
Health‐related quality of life in patients with steroid‐refractory acute graft‐versus‐host disease.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 240, doi. 10.1111/ejh.13987
- By:
- Publication type:
- Article
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs?
- Published in:
- Breast Cancer: Targets & Therapy, 2023, v. 15, p. 147, doi. 10.2147/BCTT.S387375
- By:
- Publication type:
- Article
Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision model.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 676, doi. 10.1111/ejh.13158
- By:
- Publication type:
- Article
A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 2, p. 198, doi. 10.1111/ejh.12571
- By:
- Publication type:
- Article
Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 5, p. 398, doi. 10.1111/ejh.12264
- By:
- Publication type:
- Article
Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 9, p. 604, doi. 10.1016/j.clml.2024.04.004
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of MammaPrint<sup>®</sup> to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 8, p. 981, doi. 10.1007/s40273-023-01277-4
- By:
- Publication type:
- Article
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 4, p. e213497, doi. 10.1001/jamanetworkopen.2021.3497
- By:
- Publication type:
- Article
Changes in survival in de novo metastatic cancer in an era of new medicines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 628, doi. 10.1093/jnci/djad020
- By:
- Publication type:
- Article